Spatial transcriptomics reveals prognosis‐associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment
Clinical and Translational Medicine · 2024-03 · 14 (3)
DOI: 10.1002/ctm2.1594 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024-03. Verfasst von Kai Yan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Introducing Innovative and Entrepreneurial Teams, National Natural Science Foundation of China, Key-Area Research and Development Program of Guangdong Province.
Abstract (Originalsprache)
Background
Papillary thyroid carcinoma (PTC) is the most common malignant endocrine tumour, and its incidence and prevalence are increasing considerably. Cellular heterogeneity in the tumour microenvironment is important for PTC prognosis. Spatial transcriptomics is a powerful technique for cellular heterogeneity study.
Methods
In conjunction with a clinical pathologist identification method, spatial transcriptomics was employed to characterise the spatial location and RNA profiles of PTC‐associated cells within the tissue sections. The spatial RNA‐clinical signature genes for each cell type were extracted and applied to outlining the distribution regions of specific cells on the entire section. The cellular heterogeneity of each cell type was further revealed by ContourPlot analysis, monocle analysis, trajectory analysis, ligand–receptor analysis and Gene Ontology enrichment analysis.
Results
The spatial distribution region of tumour cells, typical and atypical follicular cells (FCs and AFCs) and immune cells were accurately and comprehensively identified in all five PTC tissue sections. AFCs were identified as a transitional state between FCs and tumour cells, exhibiting a higher resemblance to the latter. Three tumour foci were shared among all patients out of the 13 observed. Notably, tumour foci No. 2 displayed elevated expression levels of genes associated with lower relapse‐free survival in PTC patients. We discovered key ligand–receptor interactions, including LAMB3–ITGA2, FN1–ITGA3 and FN1–SDC4, involved in the transition of PTC cells from FCs to AFCs and eventually to tumour cells. High expression of these patterns correlated with reduced relapse‐free survival. In the tumour immune microenvironment, reduced interaction between myeloid‐derived TGFB1 and TGFBR1 in tumour focus No. 2 contributed to tumourigenesis and increased heterogeneity. The spatial RNA‐clinical analysis method developed here revealed prognosis‐associated cellular heterogeneity in the PTC microenvironment.
Conclusions
The occurrence of tumour foci No. 2 and three enhanced ligand–receptor interactions in the AFC area/tumour foci reduced the relapse‐free survival of PTC patients, potentially leading to improved prognostic strategies and targeted therapies for PTC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
- Chronic Disease Laboratory, Institutes for Life Sciences, South China University of Technology, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou, China.
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, China.
- Department of Thyroid Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
ORCID-Profile: Bo Xu
Förderung
- Guangdong Introducing Innovative and Entrepreneurial Teams
- National Natural Science Foundation of China
- Key-Area Research and Development Program of Guangdong Province
- Guangzhou Municipal Science and Technology Bureau
Zitieren
APA
Yan, K., Liu, Q. Z., Huang, R. R., Jiang, Y. H., Bian, Z. H., Li, S. J., Li, L., Shen, F., Tsuneyama, K., Zhang, Q. L., Lian, Z. X., Guan, H., & Xu, B. (2024). Spatial transcriptomics reveals prognosis‐associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment. Clinical and Translational Medicine, 14(3). https://doi.org/10.1002/ctm2.1594
Vancouver
Yan K, Liu QZ, Huang RR, Jiang YH, Bian ZH, Li SJ, et al. Spatial transcriptomics reveals prognosis‐associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment. Clinical and Translational Medicine. 2024;14(3). doi:10.1002/ctm2.1594
BibTeX
@article{Yan2024,
author = {Yan, Kai and Liu, Qing-Zhi and Huang, Rong-Rong and Jiang, Yi-Hua and Bian, Zhen-Hua and Li, Si-Jin and Li, Liang and Shen, Fei and Tsuneyama, Koichi and Zhang, Qing-Ling and Lian, Zhe-Xiong and Guan, Haixia and Xu, Bo},
title = {Spatial transcriptomics reveals prognosis‐associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {3},
doi = {10.1002/ctm2.1594}
}
EUVIMED